Søgning på udtrykket 'covid' giver 83 resultater


Dokumenter [11] Sider [2] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Udarbejdet i samarbejde mellem DSOG og Dansk Infektionsmedicinsk Selskab

Invitation til møde den 20. maj 2022

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sotrovimab anbefales ikke længere til behandling af tidlig COVID-19 med Omicron BA.2

Sider [2]

…andling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport, COVID-19: Marie Helleberg/Jens Lundgren, Lothar Wiese, Michael Dalager-Pedersen, Merete Storgaard, Isik Somuncu Johansen og Gitte Kronborg COVID-19 retningslinje, Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende c…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Infection
27.01.2023
. Abstract. . Propose. Pregnancy is a risk factor for severe COVID-19. Treatment with monoclonal antibodies has been shown to decrease the risk of progression to severe COVID-19, but there are few reports on treating pregnant women. Here, we describe the clinical outcome of seven hospitalized pregnant women treated with the casirivimab–imdevimab. . . Methods/Res…
Infection
27.01.2023
. Abstract. . Purpose. This multicenter observational study was done to evaluate risk factors related to the development of BSI in patients admitted to ICU for COVID-19. . . Methods. All patients with COVID-19 admitted in two COVID-19 dedicated ICUs in two different hospital between 02–2020 and 02–2021 were recruited. …
Infection
27.01.2023
… Abstract. . Purpose. Reactive arthritis is acute aseptic arthritis occurring 1 to 4 weeks after a distant infection in a genetically predisposed individual. It may occur after COVID-19 infection. We summarize, in this article, the current findings of reactive arthritis following COVID-19 infection. . . Methods. A literature …
Infection
27.01.2023
. Abstract. . Purpose. The benefits of antiviral treatment with remdesivir in hospitalized patients with COVID-19 remain controversial. Clinical analyses are needed to demonstrate which patient populations are most likely to benefit. . . Methods. In a retrospective monocentric analysis, patients with COVID-19 treated between July 1, 2020 and …
Clinical Infectious Diseases
26.01.2023
AbstractBackgroundImmunoassays designed to detect SARS-CoV-2 protein antigens (Ag) are commonly used to diagnose COVID-19. The most widely used tests are lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-care. Higher throughput, laboratory-based SARS-CoV-2 Ag assays have also been developed. The number of commercially available SARS-CoV-2 Ag detection tests has increased rapidly, as has the COVID-19 diagnostic literature. The Infectious Diseases Society of…
PLoS One Infectious Diseases
26.01.2023
by Emily Cooper, Adam Lound, Christina J. Atchison, Matthew Whitaker, Caroline Eccles, Graham S. Cooke, Paul Elliott, Helen Ward. Background Long COVID is a patient-made term describing new or persistent symptoms experienced following SARS-CoV-2 infection. The Real-time Assessment of Community Transmission-Long COVID (REACT-LC) study aims to understand variation in experiences following infection, and to identify biological, social, and environmental factors associated with Long COVID. We undertook a pilot …
Infection
25.01.2023
… Abstract. . Purpose. The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has caused substantial mortality worldwide. We investigated clinical and demographic features of COVID-19-related deaths that occurred between March 2020 and January 2022 in Regensburg, Germany. . . Methods. We compared data across four consecutive time periods: March 2020 to …
PLoS One Infectious Diseases
25.01.2023
by Georgina Drago, Francisco Javier Pérez-Sádaba, Susana Aceituno, Carla Gari, Juan Luis López-Belmonte. Objectives Describe healthcare resource use and costs per hospitalized coronavirus disease-2019 (COVID-19) patient during the three main outbreak waves. Methods A retrospective observational study. COVID-19 patient data were collected from a dataset from 17 hospitals in the HM Hospitals Group. Mean total costs per hospitalized patient and per day were estimated in each wave, as defined by the Spanish…
PLoS One Infectious Diseases
25.01.2023
by Alexandros Chrysos, Iakovos Amygdalos, Priscila Nunes, Guenter Haselow, Konstantinos Lioupis, Raphael Rosch, Roman Marius Eickhoff, Georg Wiltberger, Ulf Peter Neumann, Andreas Lambertz. This study aimed to observe the impact of the COVID-19 outbreak on acute general surgery in the first German “hotspot” regions of Heinsberg and Aachen, during the first months of the pandemic. The incidence and severity of acute appendicitis, acute cholecystitis and mechanical bowel obstruction, were compared between…
PLoS One Infectious Diseases
25.01.2023
…uwafemi Adeniyi, Olajumoke Babatunde, Nathaniel Akintunde, Ganiu Ayinla, Oluwatosin Wuraola Akande, Rasheed Adekeye Odunola, Mohammed Jimoh Saka, Omotosho Ibrahim Musa, Idayat Adenike Durotoye, Chikwe Ihekweazu, Ifedayo Morayo Adetifa, Abayomi Fadeyi. The COVID-19 global pandemic is being driven by evolving SARS-CoV-2 variants with consequential implications on virus transmissibility, host immunity, and disease severity. Continuous molecular and genomic surveillance of the SARS-CoV-2 variants is therefore n…
PLoS One Infectious Diseases
25.01.2023
…h, Lulu Abebe, Bereket Duko. Background Smartphone and social media use are supposed to be integral parts of university students’ daily lives. More specifically, smartphones and social media are frequently used for communication in daily life during the COVID-19 pandemic. Nonetheless, uninterrupted and persistent use of these technologies may lead to several psychological problems. Even though smartphones and social media were used more frequently during the pandemic, there is no evidence suggesting that …
PLoS One Infectious Diseases
25.01.2023
by Shun Sun Wong, Charng Choon Wong, Kwok Wen Ng, Mohammad F. Bostanudin, Suk Fei Tan. Introduction This study aims to assess the impacts of COVID-19 pandemics among university students in Malaysia, by identifying the prevalence of depression, anxiety and stress among them and their respective predictors. Methodology An online cross-sectional study was conducted via non-probabilistic convenience sampling. Data were collected on sociodemographic characteristics, lifestyle, COVID-19 related influences. Menta…
PLoS One Infectious Diseases
25.01.2023
by Alice Bertoletti, Mara Soncin, Marta Cannistrà, Tommaso Agasisti. The disruption caused by the Covid-19 pandemic generated an unprecedented situation, in which digital learning, in the form of Emergency Remote Teaching, was the only possible form of schooling. Italy soon decided to close schools as a measure to counter the spread of the virus. Although the Ministry of Education suggested general guidelines, school principals and teachers were autonomous in deciding how to best organise their educational…
New England Journal of Medicine
25.01.2023
New England Journal of Medicine, Volume 388, Issue 4, January 2023.
Infection
25.01.2023
… Abstract. . Purpose. The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has caused substantial mortality worldwide. We investigated clinical and demographic features of COVID-19-related deaths that occurred between March 2020 and January 2022 in Regensburg, Germany. . . Methods. We compared data across four consecutive time periods: March 2020 to …
BMC Infectious Diseases
25.01.2023
. Abstract. . Background. Around the world, policymakers have clearly communicated that COVID-19 vaccination programs need to be accepted by a large proportion of the population to allow life return to normal. However, according to the Center for Disease Control, about 31% of the United States population had not completed the primary vaccination series as of November 2022. . . …
BMC Infectious Diseases
25.01.2023
. Abstract. . Background. Post-COronaVIrus Disease 2019 (COVID-19) conditions (PCC) include multiple symptoms afflicting different organs and systems. To evaluate the frequency and type of them, we described our multidisciplinary approach with preliminary results of the first enrolled patients. . . Methods. We included patients aged ≥ 1…
Journal of the American Medical Association
25.01.2023
The COVID-19 pandemic caught society unprepared. The lack of therapeutic agents for coronaviruses led to a scramble to investigate approved medications for repurposing against SARS-CoV-2. Successes were achieved with immunomodulatory agents for the inflammatory disease processes of COVID-19, but the antiviral search has been less productive. One of the more interesting therapeutic candidates investigated is fluvoxamine.
Journal of the American Medical Association
25.01.2023
This randomized, placebo-controlled platform trial compares the use of low-dose fluvoxamine (50 mg twice daily) for 10 days compared with placebo in outpatients with mild to moderate COVID-19.
International Journal of Infectious Diseases
25.01.2023
On 29 January 2020, the first SARS-CoV-2 case was notified in Italy [1,2] and, by 21 February 2022, almost 12 million confirmed cases and 150,000 deaths from COVID-19 had been recorded in the country [3].

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
27.01.2023
The FDA's vaccine advisers lent support to the agency's plan to try to simplify future COVID shots, with an aim of having many people get just one dose in the fall. . Medscape Medical News
Medscape Infectious Diseases
27.01.2023
The proportion of Californians dying at home, rather than in a hospital or nursing home, accelerated during the pandemic, a trend that has outlasted the rigid lockdowns linked to the initial shift. . Kaiser Health News
Medscape Infectious Diseases
27.01.2023
Fewer than 11% of eligible Floridians have received an updated booster vaccine, according to the CDC. Research into the efficacy of the bivalent booster in preventing infection continues. . Kaiser Health News
Medscape Infectious Diseases
27.01.2023
The dollar figures are just part of an emerging picture of how the illness is impacting not just patients, but their employers and the wider labor market. . WebMD Health News
Morbidity and Mortality Weekly Report (MMWR)
27.01.2023
This report describes a broadened antibody response among nursing home residents who received an updated COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
27.01.2023
This report describes lower weekly rates of COVID-19 among nursing home residents who are up to date with COVID-19 vaccination.
Statens Serum Institut
26.01.2023
Eurosurveillance latest updates
26.01.2023
We analysed SARS-CoV-2 PCR Cq values from 3,183 healthcare workers who tested positive between January and August 2022. Median Cq values were lower in symptomatic than in asymptomatic HCW. The difference in Cq values between HCW with mild vs moderate/severe symptoms was statistically significant but negligibly small. To prevent nosocomial infections, all symptomatic HCW should be tested irrespective of symptom severity. This information can support decisions on testing and isolation, in the context of ongoi…
Medscape Infectious Diseases
25.01.2023
Is pivoting to an annual COVID-19 shot a smart move? . WebMD Health News
Medscape Infectious Diseases
25.01.2023
The co-author of a new study on long COVID is also a long COVID patient. She shares her story as a patient and of her work to study its origins, what we know, and what we need to do. . Medscape Medical News
Medscape Infectious Diseases
25.01.2023
US health officials want to simplify the recommended COVID-19 vaccine protocol. . WebMD Health News
Statens Serum Institut
25.01.2023
I efteråret 2022 blev alle over 50 år tilbudt et 4. stik for at øge beskyttelsen mod covid-19. Der blev tilbudt en opdateret covid-19-vaccine, der skulle beskytte bedre mod omikronvarianten, der herskede på det tidspunkt. Nu viser resultater fra en stor fælles nordisk kortlægning, at dette også var tilfældet.
ProMED
22.01.2023
COVID-19 -- ChinaOn 19 Jan 2023, there were 471 739 hospitalized cases of COVID-19 infection in 31 provinces (autonomous regions and municipalities directly under the central government) and Xinjiang Production and Construction Corps, with 51 683 severe cases, including 3874 severe cases of COVID-19 infection[s] and 47 809 cases of COVID-19 infections with severe underlying medical conditions. From 13 to 19 Jan 2023, there were a total of 12 658 COVID-19-related deaths in 31 provinces and medical institutio…
Medscape Infectious Diseases
21.01.2023
The nation's first case of COVID-19 was diagnosed in Snohomish County, Washington, on January 20, 2020. . WebMD Health News
Medscape Infectious Diseases
21.01.2023
The drugs' effects go beyond LDL-lowering in ways that might potentially benefit hospitalized patients with COVID-19, at least those who are sickest, preliminary results suggest. . Medscape Medical News
Medscape Infectious Diseases
21.01.2023
It’s called “hybrid immunity” and it offers better protection from COVID reinfection. . WebMD Health News
Morbidity and Mortality Weekly Report (MMWR)
20.01.2023
This report describes an online survey of previously vaccinated residents and their reasons for not getting a bivalent COVID-19 booster dose.
Medscape Infectious Diseases
19.01.2023
When should we think about the next COVID-19 vaccine? Or should we? . WebMD Health News

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2023 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.0
PHP version: 8.0.27
Design: Christian Philip Fischer
Side indlæst på 0.49 s

Cookies og privatliv